These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
235 related articles for article (PubMed ID: 10207098)
1. Role for Hsp90-associated cochaperone p23 in estrogen receptor signal transduction. Knoblauch R; Garabedian MJ Mol Cell Biol; 1999 May; 19(5):3748-59. PubMed ID: 10207098 [TBL] [Abstract][Full Text] [Related]
2. Genetic dissection of p23, an Hsp90 cochaperone, reveals a distinct surface involved in estrogen receptor signaling. Oxelmark E; Knoblauch R; Arnal S; Su LF; Schapira M; Garabedian MJ J Biol Chem; 2003 Sep; 278(38):36547-55. PubMed ID: 12835317 [TBL] [Abstract][Full Text] [Related]
3. Cooperation of heat shock protein 90 and p23 in aryl hydrocarbon receptor signaling. Cox MB; Miller CA Cell Stress Chaperones; 2004 Mar; 9(1):4-20. PubMed ID: 15270073 [TBL] [Abstract][Full Text] [Related]
4. Genetic and biochemical analysis of p23 and ansamycin antibiotics in the function of Hsp90-dependent signaling proteins. Bohen SP Mol Cell Biol; 1998 Jun; 18(6):3330-9. PubMed ID: 9584173 [TBL] [Abstract][Full Text] [Related]
5. Research resource: enhanced genome-wide occupancy of estrogen receptor α by the cochaperone p23 in breast cancer cells. Simpson NE; Gertz J; Imberg K; Myers RM; Garabedian MJ Mol Endocrinol; 2012 Jan; 26(1):194-202. PubMed ID: 22074947 [TBL] [Abstract][Full Text] [Related]
6. Probing the structure and function of the estrogen receptor ligand binding domain by analysis of mutants with altered transactivation characteristics. Eng FC; Lee HS; Ferrara J; Willson TM; White JH Mol Cell Biol; 1997 Aug; 17(8):4644-53. PubMed ID: 9234721 [TBL] [Abstract][Full Text] [Related]
7. High levels of Hsp90 cochaperone p23 promote tumor progression and poor prognosis in breast cancer by increasing lymph node metastases and drug resistance. Simpson NE; Lambert WM; Watkins R; Giashuddin S; Huang SJ; Oxelmark E; Arju R; Hochman T; Goldberg JD; Schneider RJ; Reiz LF; Soares FA; Logan SK; Garabedian MJ Cancer Res; 2010 Nov; 70(21):8446-56. PubMed ID: 20847343 [TBL] [Abstract][Full Text] [Related]
8. The p23 molecular chaperones act at a late step in intracellular receptor action to differentially affect ligand efficacies. Freeman BC; Felts SJ; Toft DO; Yamamoto KR Genes Dev; 2000 Feb; 14(4):422-34. PubMed ID: 10691735 [TBL] [Abstract][Full Text] [Related]
9. Interaction and dissociation by ligands of estrogen receptor and Hsp90: the antiestrogen RU 58668 induces a protein synthesis-dependent clustering of the receptor in the cytoplasm. Devin-Leclerc J; Meng X; Delahaye F; Leclerc P; Baulieu EE; Catelli MG Mol Endocrinol; 1998 Jun; 12(6):842-54. PubMed ID: 9626660 [TBL] [Abstract][Full Text] [Related]
10. Hormone-dependent transactivation by estrogen receptor chimeras that do not interact with hsp90. Evidence for transcriptional repressors. Lee HS; Aumais J; White JH J Biol Chem; 1996 Oct; 271(42):25727-30. PubMed ID: 8824196 [TBL] [Abstract][Full Text] [Related]
11. Intracellular dynamics of the Hsp90 co-chaperone p23 is dictated by Hsp90. Picard D Exp Cell Res; 2006 Jan; 312(2):198-204. PubMed ID: 16289154 [TBL] [Abstract][Full Text] [Related]
12. Selective interaction of hsp90 with an estrogen receptor ligand-binding domain containing a point mutation. Aumais JP; Lee HS; Lin R; White JH J Biol Chem; 1997 May; 272(18):12229-35. PubMed ID: 9115298 [TBL] [Abstract][Full Text] [Related]
13. Estrogen receptor alpha and beta subtype expression and transactivation capacity are differentially affected by receptor-, hsp90- and immunophilin-ligands in human breast cancer cells. Gougelet A; Bouclier C; Marsaud V; Maillard S; Mueller SO; Korach KS; Renoir JM J Steroid Biochem Mol Biol; 2005 Feb; 94(1-3):71-81. PubMed ID: 15862952 [TBL] [Abstract][Full Text] [Related]
14. Yeast two-hybrid system demonstrates that estrogen receptor dimerization is ligand-dependent in vivo. Wang H; Peters GA; Zeng X; Tang M; Ip W; Khan SA J Biol Chem; 1995 Oct; 270(40):23322-9. PubMed ID: 7559488 [TBL] [Abstract][Full Text] [Related]
15. p23/Sba1p protects against Hsp90 inhibitors independently of its intrinsic chaperone activity. Forafonov F; Toogun OA; Grad I; Suslova E; Freeman BC; Picard D Mol Cell Biol; 2008 May; 28(10):3446-56. PubMed ID: 18362168 [TBL] [Abstract][Full Text] [Related]
16. Role of HSP90 in mediating cross-talk between the estrogen receptor and the Ah receptor signal transduction pathways. Caruso JA; Laird DW; Batist G Biochem Pharmacol; 1999 Nov; 58(9):1395-403. PubMed ID: 10513983 [TBL] [Abstract][Full Text] [Related]
18. Control of estrogen receptor ligand binding by Hsp90. Fliss AE; Benzeno S; Rao J; Caplan AJ J Steroid Biochem Mol Biol; 2000 Apr; 72(5):223-30. PubMed ID: 10822011 [TBL] [Abstract][Full Text] [Related]
19. Regulation of signaling protein function and trafficking by the hsp90/hsp70-based chaperone machinery. Pratt WB; Toft DO Exp Biol Med (Maywood); 2003 Feb; 228(2):111-33. PubMed ID: 12563018 [TBL] [Abstract][Full Text] [Related]
20. The N-terminal adenosine triphosphate binding domain of Hsp90 is necessary and sufficient for interaction with estrogen receptor. Bouhouche-Chatelier L; Chadli A; Catelli MG Cell Stress Chaperones; 2001 Oct; 6(4):297-305. PubMed ID: 11795466 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]